Filters close
Released: 8-Aug-2022 10:05 AM EDT
Triple Therapy Halved the Risk of Death Among Patients Hospitalized With Severe COVID-19
Rutgers University-New Brunswick

Adding baricitinib to remdesivir and dexamethasone improved outcomes among patients hospitalized with Covid-19, according to a Rutgers researcher



close
0.15794